HNF1A and central nervous system cancer: MiR‐32‐5p inhibition obviously restored the oncogenic effects of HNF1A‐AS1 in glioma cell proliferation (Figure 3I), apoptosis (Figure 3J,K; Figure S1B), migration (Figure 3L; Figure S1C), and invasion (Figure 3M; Figure S1D).